Wednesday, November 10, 2010: 12:30 PM
Grand Ballroom B (Salt Palace Convention Center)
Description:
The quality by design paradigm has rapidly increased the adoption of multivariate data analysis in Pharmaceutical Development. The application of these powerful techniques on experimental, process, or PAT data can result in significant increases of development productivity and substantial reduction of process risk. Authors are encouraged to submit papers discussing case studies in which multivariate data analysis was applied to increase process understanding to improve process robustness and performance or decrease development time.
Sponsor:
Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Co-Sponsor(s):
Pharmaceuticals (15b)
Chair:
Co-Chair:
- indicates paper has an Extended Abstract file available on CD.
See more of this Group/Topical: Topical i : Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
![[ Visit Client Website ]](images/banner.gif)